Capital Fund Management S.A. Intercept Pharmaceuticals, Inc. Transaction History

Capital Fund Management S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$12.99 - $20.47 $255,682 - $402,911	-19,683 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$15.46 - $24.5 $551,566 - $874,086	-35,677 Reduced 64.45%	19,683 $393,000
Q1 2021 May 14, 2021	BUY	$19.33 - $37.75 $546,497 - $1.07 Million	28,272 Added 104.37%	55,360 $1.28 Million
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $418,412 - $725,897	17,092 Added 170.99%	27,088 $669,000
Q4 2019 Feb 13, 2020	SELL	$57.36 - $124.1 $97,110 - $210,101	-1,693 Reduced 14.48%	9,996 $1.24 Million
Q2 2019 Aug 12, 2019	BUY	$77.77 - $120.68 $250,108 - $388,106	3,216 Added 37.96%	11,689 $930,000
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $726,898 - $1.07 Million	8,473 New	8,473 $854,000
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $392,760 - $560,795	-6,546 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $345,105 - $440,218	6,546 New	6,546 $403,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.